Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
about
Pleiotropic effects of statinsUric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling.Lovastatin inhibits oxidized L-A-phosphatidylcholine B-arachidonoyl-gamma-palmitoyl (ox-PAPC)-stimulated interleukin-8 mRNA and protein synthesis in human aortic endothelial cells by depleting stores of geranylgeranyl pyrophosphate.Platelets and their chemokines in atherosclerosis-clinical applications.3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.ACAT inhibition and amyloid beta reduction.Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.Sexual dimorphism in reduced-size liver ischemia and reperfusion injury in mice: role of endothelial cell nitric oxide synthasePharmacological approaches to preserving and restoring coronary endothelial function.Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation.Why might statins prevent venous thromboembolism: what needs to be done to know more?Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.Beyond lipid-lowering: effects of statins on endothelial nitric oxide.Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanismSimvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypassConceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.Hypercholesterolemia: its impact on ischemia-reperfusion injury.Inflammation in coronary artery disease: potential role for immunomodulatory therapy.Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failureProgressive stent technologies: new approaches for the treatment of cardiovascular diseases.Drug-eluting stents - what should be improved?Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.Simvastatin promotes NPC1-mediated free cholesterol efflux from lysosomes through CYP7A1/LXRα signalling pathway in oxLDL-loaded macrophages.Simvastatin protects ischemic spinal cord injury from cell death and cytotoxicity through decreasing oxidative stress: in vitro primary cultured rat spinal cord model under oxygen and glucose deprivation-reoxygenation conditionsHMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct sizeDo statins have a role in reduction/prevention of post-PCI restenosis?Statins as modulators of regulatory T-cell biology.Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation.Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells.Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction.Effects of statins on vascular function of endothelin-1.Effects of statins on adhesion molecule expression in endothelial cells.HMG-CoA reductase inhibitor attenuates platelet adhesion in intestinal venules of hypercholesterolemic mice.Estrogen receptor-alpha, sexual dimorphism and reduced-size liver ischemia and reperfusion injury in mice.Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.Therapeutic effects of a combinatorial treatment of simvastatin and bone marrow stromal cells on experimental embolic stroke.
P2860
Q24647863-B7F3BA6E-FA24-4B92-969A-72B01155AC62Q24678615-63A42E79-84B0-4AE6-9896-A7470F8C7710Q33555656-7BF472F9-5F15-4E02-A2F0-DC0F9AB7E5DCQ33618639-7DE9B517-0E56-4C96-968B-F47C0CD7CE27Q34019069-365C5B0B-B450-4630-A309-7ABE383978E8Q34032435-AD3380E4-B65C-4A5D-93C6-486CF9A0F402Q34052308-1731DAE8-A9A0-4FBE-9824-324F0FB454EEQ34219598-7011886D-A889-4A96-AB07-4E69182F2A41Q34470658-1D34BC65-A55E-4C02-B78E-CCC160A61044Q34515458-21B56F8B-8E22-4065-BBEA-9254CAE5B2D5Q34778613-DFB96EC3-F975-4B6F-87D4-ABF0EF7E4CBBQ35001052-46A02F17-C320-4F1D-AD81-D037721460A2Q35047687-ABBEBBAA-8009-4A92-916E-96EDF5CAF05CQ35084723-D0695008-AF83-4A08-B819-5DB57D638057Q35230306-4DAB6DFD-8B19-41CE-96B5-FEC603A6507CQ35581141-2D16CBD7-CDE0-4569-A6AF-D299DE00F2C8Q35639538-4736A6E1-95E2-4C33-AD92-0B5495225CB3Q36242351-3F589402-CB2D-46E6-A674-B4058420A0DCQ36314857-6B9F3DBF-C97E-4C50-86FF-23BF82E2FFEDQ36314881-E1612AA8-8173-4D36-900B-70FA557CD4CDQ36529070-B259CF9A-C147-467C-AEAA-F7F47D3592EFQ36640339-48A37F67-D169-48C0-9C4F-3C3808ABA910Q37144221-14D7AEEB-ACAC-4FF7-9B1B-60BABD7B8CD8Q37511128-5915414A-E701-4B58-9739-2C0B1154A26DQ37578459-5D9FDBA5-E53E-451F-9345-DA37FB8D18D0Q37604358-635E3CE9-14E4-4025-A62C-395F686FF801Q37671313-ADC07EDF-EA20-4240-9166-71512D55E69FQ37728825-36C581D9-8629-45A4-8B7A-E0BA7BDED3C0Q37941867-2CF9A925-C4A6-4A3C-BAF5-448D5075CDFDQ38162189-C708A0C7-3556-48B0-BBDB-2DCA957E3DAFQ38538168-B805B6F7-2B3D-4A17-AFC6-365191EC5484Q39547616-A7B1F4CA-76E2-416C-AA87-D587C0933D53Q41489698-757ED6E5-6BBA-4B47-B4FB-91702B4BAFE9Q42523851-33CA1AF2-F3DE-4891-A9EC-612AF5FE2742Q42789787-41730DF6-A1F1-466A-ADC2-8351D00DC581Q44663084-3C1CE384-7B89-4347-9D04-2BAA88AA6AC7Q44704956-78E89624-250D-45C5-8F70-084EC63006C9Q44719328-31C659D2-02B0-4CE2-9AFD-5E4FDBF6DE3EQ45241719-3C4C9250-3AB4-45BB-8A9C-FEA807E15EE3Q46235610-36AA33D5-3EA1-4AB9-A5CD-78B6C8FE6DC4
P2860
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vascular effects of HMG CoA-re ...... ts for cardiovascular disease.
@ast
Vascular effects of HMG CoA-re ...... ts for cardiovascular disease.
@en
type
label
Vascular effects of HMG CoA-re ...... ts for cardiovascular disease.
@ast
Vascular effects of HMG CoA-re ...... ts for cardiovascular disease.
@en
prefLabel
Vascular effects of HMG CoA-re ...... ts for cardiovascular disease.
@ast
Vascular effects of HMG CoA-re ...... ts for cardiovascular disease.
@en
P1476
Vascular effects of HMG CoA-re ...... pts for cardiovascular disease
@en
P2093
P304
P356
10.1016/S0008-6363(00)00247-9
P577
2001-02-01T00:00:00Z